FDA Approved: NEFFY — Supplemental Application (ARS Pharmaceuticals Operations, Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for NEFFY (epinephrine) from ARS Pharmaceuticals Operations, Inc., expanding its use for emergency treatment of anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• NEFFY (epinephrine)

Snippet

SUPPL AP for NEFFY (EPINEPHRINE)